These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24726415)

  • 1. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
    Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
    Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
    Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.
    Stegeman H; Rademakers SE; Span PN; Takes RP; van der Kogel AJ; Kaanders JH; Bussink J
    Head Neck; 2014 Sep; 36(9):1288-95. PubMed ID: 24668936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and predictive significance of SIRT1 and peroxisome proliferator-activated receptor gamma in esophageal squamous cell carcinoma: The correlation with EGFR and Survivin.
    Han F; Zhang S; Liang J; Qiu W
    Pathol Res Pract; 2018 May; 214(5):686-690. PubMed ID: 29625788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.
    Owusu-Afriyie O; Owiredu WKBA; Owusu-Danquah K; Komarck C; Foltin SK; Larsen-Reindorf R; Acheampong E; Quayson SE; Prince MEP; McHugh JB; Donkor P; Merajver SD; Brenner JC
    PLoS One; 2018; 13(8):e0202790. PubMed ID: 30138436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PTEN and survivin in cervical cancer: promising biological markers for early diagnosis and prognostic evaluation.
    Lu D; Qian J; Yin X; Xiao Q; Wang C; Zeng Y
    Br J Biomed Sci; 2012; 69(4):143-6. PubMed ID: 23310986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.
    Nijkamp MM; Hoogsteen IJ; Span PN; Takes RP; Lok J; Rijken PF; van der Kogel AJ; Bussink J; Kaanders JH
    Radiother Oncol; 2011 Oct; 101(1):165-70. PubMed ID: 21775008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
    García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
    Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.
    Farnebo L; Tiefenböck K; Ansell A; Thunell LK; Garvin S; Roberg K
    Int J Cancer; 2013 Oct; 133(8):1994-2003. PubMed ID: 23564498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
    Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK
    Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.
    Ko YH; Roh SY; Won HS; Jeon EK; Hong SH; Lee MA; Kang JH; Hong YS; Kim MS; Jung CK
    Head Neck Oncol; 2010 Oct; 2():30. PubMed ID: 21034499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sprouty2 protein is downregulated in human squamous cell carcinoma of the head and neck and suppresses cell proliferation in vitro.
    Lin CL; Chiang WF; Tung CL; Hsieh JL; Hsiao JR; Huang WT; Feng LY; Chang CH; Liu SY; Tsao CJ; Feng YH
    Mol Med Rep; 2015 Jan; 11(1):547-54. PubMed ID: 25333206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in expression of EGFR, pAkt, and PTEN between oropharyngeal and oral cavity squamous cell carcinoma.
    Won HS; Jung CK; Chun SH; Kang JH; Kim YS; Sun DI; Kim MS
    Oral Oncol; 2012 Oct; 48(10):985-990. PubMed ID: 22682934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma.
    Chung CH; Zhang Q; Hammond EM; Trotti AM; Wang H; Spencer S; Zhang HZ; Cooper J; Jordan R; Rotman MH; Ang KK
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):331-8. PubMed ID: 20732768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
    Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
    Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential imaging targets in primary head and neck squamous cell carcinoma and lymph node metastases.
    van Schaik JE; van der Vegt B; Slagter-Menkema L; Hanemaaijer SH; Halmos GB; Witjes MJH; van der Laan BFAM; Fehrmann RSN; Oosting SF; Plaat BEC
    Am J Otolaryngol; 2024; 45(4):104298. PubMed ID: 38640809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
    Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
    Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
    Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
    Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.